Home > Boards > US OTC > Biotechs > Ampio Pharmaceuticals, Inc (AMPE)

On June 14, 2019, the Company issued a

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
m1999 Member Profile
Member Level 
Followed By 797
Posts 57,670
Boards Moderated 34
Alias Born 03/10/09
160x600 placeholder
Quarterly Report (10-q) Edgar (US Regulatory) - 11/7/2019 4:34:23 PM
Proxy Statement (definitive) (def 14a) Edgar (US Regulatory) - 10/31/2019 4:31:35 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 10/29/2019 6:03:00 AM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 10/21/2019 4:36:09 PM
Proxy Statement - Notice of Shareholders Meeting (preliminary) (pre 14a) Edgar (US Regulatory) - 10/16/2019 4:03:18 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 10/10/2019 4:02:31 PM
Ampio Provides Update on Continued Progress of AP-013 Phase III Clinical Trial and Manufacturing Facility PR Newswire (US) - 10/10/2019 8:30:00 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 9/20/2019 4:02:57 PM
Ampio Retains Legal Counsel for Transaction Advisory Committee PR Newswire (US) - 9/18/2019 8:30:00 AM
Ampio Pharmaceuticals Updates Progress of SPA Clinical Trial PR Newswire (US) - 9/17/2019 8:30:00 AM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 9/11/2019 5:47:09 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 9/11/2019 5:32:22 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 9/11/2019 5:13:54 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 8/23/2019 4:03:17 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 8/22/2019 3:05:35 PM
Ampio Pharmaceuticals Retains Financial Advisor and Appoints Transaction Advisory Committee PR Newswire (US) - 8/22/2019 8:30:00 AM
Quarterly Report (10-q) Edgar (US Regulatory) - 8/9/2019 4:04:18 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 8/1/2019 5:23:37 PM
Initial Statement of Beneficial Ownership (3) Edgar (US Regulatory) - 8/1/2019 5:01:31 PM
Ampio Pharmaceuticals Updates Progress of SPA Clinical Trial PR Newswire (US) - 7/25/2019 8:30:00 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 7/11/2019 4:02:23 PM
Ampio Appoints Moss Adams LLP as the Company's New Independent Auditor PR Newswire (US) - 7/11/2019 8:30:00 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 7/10/2019 4:03:12 PM
Ampio Appoints Dan Stokely as the Company's new Chief Financial Officer PR Newswire (US) - 7/10/2019 8:30:00 AM
Statement of Ownership (sc 13g) Edgar (US Regulatory) - 6/20/2019 3:47:52 PM
m1999 Member Level  Friday, 06/14/19 10:16:53 PM
Re: m1999 post# 696
Post # of 740 
On June 14, 2019, the Company issued a press release announcing the commencement of a proposed offering of shares of its common stock in an underwritten public offering. The Company intends to grant the underwriters a 45-day option to purchase additional shares of its common stock. The offering is subject to market and other conditions, and there can be no assurance as to whether or when the offering may be completed, or as to the actual size or terms of the offering.


STOP & VISIT MY BOARD AT: HOTTEST PENNY STOCK PICKS

http://investorshub.advfn.com/boards/board.aspx?board_id=19627

My posts are NOT a buy/sell recommendation, Do your Own DD, before you buy any stock - I reserve the right to buy/sell any stock
Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist